The latest closing stock price for Viridian Therapeutics as of September 19, 2024 is 22.50.
An investor who bought $1,000 worth of Viridian Therapeutics stock at the IPO in 2014 would have $-989 today, roughly -1 times their original investment - a -36.30% compound annual growth rate over 10 years.
The all-time high Viridian Therapeutics stock closing price was 2045.25 on June 18, 2014.
The Viridian Therapeutics 52-week high stock price is 24.18, which is 7.5% above the current share price.
The Viridian Therapeutics 52-week low stock price is 10.93, which is 51.4% below the current share price.
The average Viridian Therapeutics stock price for the last 52 weeks is 16.13.
An investor who bought $1,000 worth of Viridian Therapeutics stock at the IPO in 2014 would have $-989 today, roughly -1 times their original investment - a -36.30% compound annual growth rate over 10 years.
The all-time high Viridian Therapeutics stock closing price was 2045.25 on June 18, 2014.
The Viridian Therapeutics 52-week high stock price is 24.18, which is 7.5% above the current share price.
The Viridian Therapeutics 52-week low stock price is 10.93, which is 51.4% below the current share price.
The average Viridian Therapeutics stock price for the last 52 weeks is 16.13.